Petros Pharmaceuticals, Inc.
Q4 2023 13F Holders
Symbol
PTPI
CUSIP
71678J209
Type
Equity
Class
COM NEW
Num filings
18
Total reported value, excl. options
$165 k
Compare 2023 Q4 to
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q3
2023 Q2
2023 Q1
2022 Q4
Manager
Report Date
Value ($000)
Shares
Option Type